Cargando…
Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies
BACKGROUND: Monoclonal gammopathies encompass a wide range of diseases characterized by the monoclonal expansion of a B-cell clone. Despite emerging therapeutic strategies, chances of survival of patients who are affected are still scarce, which implies that new tools are necessary not only for the...
Autores principales: | Cigliana, Giovanni, Torti, Eleonora, Gulli, Francesca, De Santis, Elena, Dell’Abate, Maria Teresa, Colacicco, Luigi, Pisani, Francesco, Conti, Laura, Basile, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495691/ https://www.ncbi.nlm.nih.gov/pubmed/26025441 http://dx.doi.org/10.1186/s13046-015-0155-4 |
Ejemplares similares
-
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023) -
Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021) -
Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010) -
Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Minarik, Jiri, et al.
Publicado: (2012) -
Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)